(TVTX) Travere Therapeutics - Performance 215.8% in 12m
Compare TVTX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
7.15%
#28 in Group
Rel. Strength
98.96%
#84 in Universe
Total Return 12m
215.77%
#4 in Group
Total Return 5y
20.97%
#31 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -17.50%
(?) Percentile in Group
12m Total Return: TVTX (215.8%) vs XBI (-14.9%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
7.21% | 14% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
7.98% | 32.4% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-7.04% | -11.2% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
11.7% | 13.3% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
2.2% | 21% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
13.3% | 27.1% | -5.64% | 27.5 | 25.1 | 1 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
27.3% | -15% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
20% | 0.38% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: TVTX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for TVTX
Total Return (including Dividends) | TVTX | XBI | S&P 500 |
---|---|---|---|
1 Month | 38.07% | 2.77% | 5.69% |
3 Months | -15.71% | -14.21% | -6.49% |
12 Months | 215.77% | -14.88% | 9.72% |
5 Years | 20.97% | -26.47% | 107.51% |
Trend Score (consistency of price movement) | TVTX | XBI | S&P 500 |
1 Month | 89.1% | 57% | 89.4% |
3 Months | -49.2% | -82.3% | -72% |
12 Months | 83.5% | -53.1% | 49.3% |
5 Years | -51.4% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #54 | 34.4% | 30.6% |
3 Month | #41 | -1.74% | -9.86% |
12 Month | #3 | 271% | 188% |
5 Years | #32 | 64.5% | -41.7% |
FAQs
Does TVTX Travere Therapeutics outperforms the market?
Yes,
over the last 12 months TVTX made 215.77%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.88%.
Over the last 3 months TVTX made -15.71%, while XBI made -14.21%.
Over the last 3 months TVTX made -15.71%, while XBI made -14.21%.
Performance Comparison TVTX vs Indeces and Sectors
TVTX vs. Indices TVTX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -6.64% | 32.4% | 10.4% | 206% |
US NASDAQ 100 | QQQ | -6.91% | 30.7% | 9.94% | 205% |
US Dow Jones Industrial 30 | DIA | -6.53% | 35.4% | 11.4% | 210% |
German DAX 40 | DAX | -7.09% | 23.0% | -15.2% | 191% |
Shanghai Shenzhen CSI 300 | CSI 300 | -6.87% | 35.2% | 11.1% | 209% |
Hongkong Hang Seng | HSI | -9.52% | 23.2% | 0.86% | 208% |
India NIFTY 50 | INDA | -2.94% | 34.9% | 8.45% | 214% |
Brasil Bovespa | EWZ | -9.67% | 26.5% | 1.14% | 222% |
TVTX vs. Sectors TVTX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -6.01% | 31.6% | 4.17% | 195% |
Consumer Discretionary | XLY | -8.06% | 31.4% | 12.5% | 201% |
Consumer Staples | XLP | -5.78% | 37.4% | 3.44% | 209% |
Energy | XLE | -8.89% | 33.6% | 16.4% | 225% |
Financial | XLF | -7.34% | 31.2% | 4.47% | 194% |
Health Care | XLV | -2.54% | 41.1% | 15.6% | 222% |
Industrial | XLI | -7.57% | 29.8% | 9.37% | 205% |
Materials | XLB | -6.80% | 33.0% | 14.4% | 222% |
Real Estate | XLRE | -5.85% | 31.2% | 7.97% | 202% |
Technology | XLK | -7.48% | 28.4% | 12.6% | 210% |
Utilities | XLU | -7.36% | 32.9% | 2.58% | 200% |
Aerospace & Defense | XAR | -6.82% | 28.9% | 1.05% | 190% |
Biotech | XBI | 1.08% | 35.3% | 31.4% | 231% |
Homebuilder | XHB | -6.28% | 32.5% | 24.0% | 225% |
Retail | XRT | -6.70% | 31.9% | 16.6% | 222% |